Low prevalence of glucokinase gene mutations in gestational diabetic patients with good glycemic control

Genetics and Molecular Research

Volumn 11, Issue 2, 2012, Pages 1433-1441

  Frigeri, H R ^a,b   Santos, I C R ^a   Rea R R ^a   Almeida, A C R ^a   Fadel Picheth, C M T ^a   Pedrosa, F O ^a   Souza, E M ^a   Rego, F G M ^a   Picheth, G ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

GCK; Genetic susceptibility; Gestational diabetes; Glucokinase; Mutations; SNPs

Indexed keywords

GLUCOKINASE;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC VARIABILITY; GLUCOKINASE GENE; GLYCEMIC CONTROL; HUMAN; INTRON; MAJOR CLINICAL STUDY; MATERNAL NUTRITION; MUTATOR GENE; PREGNANCY DIABETES MELLITUS; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 84930478382     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.May.18.2     Document Type: Article

References (41)

1. American Diabetes Association (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care 33 (Suppl 1): S62-S69.
2. American Diabetes Association (2011). Diagnosis and classification of diabetes mellitus. Diabetes Care 34 (Suppl 1): S62-S69.
3. Arden C, Harbottle A, Baltrusch S, Tiedge M, et al. (2004). Glucokinase is an integral component of the insulin granules in glucose-responsive insulin secretory cells and does not translocate during glucose stimulation. Diabetes 53: 2346-2352.
4. Ben-Haroush A, Yogev Y and Hod M (2004). Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet. Med. 21: 103-113.
5. de la Iglesia N, Veiga-da-Cunha M, Van Schaftingen E, Guinovart JJ, et al. (1999). Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase. FEBS Lett. 456: 332-338.
6. Ellard S, Beards F, Allen LI, Shepherd M, et al. (2000). A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 43: 250-253.
7. Gloyn AL (2003). Glucokinase (GCK) mutations in hyper-and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum. Mutat. 22: 353-362.
8. Greeley SA, Tucker SE, Worrell HI, Skowron KB, et al. (2010). Update in neonatal diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 17: 13-19.
9. Grundy SM, Cleeman JI, Daniels SR, Donato KA, et al. (2006). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr. Opin. Cardiol. 21: 1-6.
10. Hayashi K (1991). PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1: 34-38.
11. Hollingsworth DR and Grundy SM (1982). Pregnancy-associated hypertriglyceridemia in normal and diabetic women. Differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Diabetes 31: 1092-1097.
12. Iynedjian PB (2009). Molecular physiology of mammalian glucokinase. Cell Mol. Life Sci. 66: 27-42.
13. Jetton TL, Liang Y, Pettepher CC, Zimmerman EC, et al. (1994). Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J. Biol. Chem. 269: 3641-3654.
14. Knopp RH, Chapman M, Bergelin R, Wahl PW, et al. (1980). Relationships of lipoprotein lipids to mild fasting hyperglycemia and diabetes in pregnancy. Diabetes Care 3: 416-420.
15. Kousta E, Ellard S, Allen LI, Saker PJ, et al. (2001). Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet. Med. 18: 683-684.
16. Lahiri DK and Nurnberger JI Jr (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19: 5444.
17. Liang Z, Dong M, Cheng Q and Chen D (2010). Gestational diabetes mellitus screening based on the gene chip technique. Diabetes Res. Clin. Pract. 89: 167-173.
18. Magnuson MA and Shelton KD (1989). An alternate promoter in the glucokinase gene is active in the pancreatic beta cell. J. Biol. Chem. 264: 15936-15942.
19. Marcinkevage JA and Narayan KM (2011). Gestational diabetes mellitus: taking it to heart. Prim. Care Diabetes 5: 81-88.
20. Matschinsky FM (2009). Assessing the potential of glucokinase activators in diabetes therapy. Nat. Rev. Drug. Discov. 8: 399-416.
21. Matschinsky FM and Ellerman JE (1968). Metabolism of glucose in the islets of Langerhans. J. Biol. Chem. 243: 2730-2736.
22. Matschinsky FM, Magnuson MA, Zelent D, Jetton TL, et al. (2006). The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55: 1-12.
23. Metzger BE, Phelps RL, Freinkel N and Navickas IA (1980). Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care 3: 402-409.
24. Metzger BE, Lowe LP, Dyer AR, Trimble ER, et al. (2008). Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358: 1991-2002.
25. Meyers-Seifer CH and Vohr BR (1996). Lipid levels in former gestational diabetic mothers. Diabetes Care 19: 1351-1356.
26. Orita M, Iwahana H, Kanazawa H, Hayashi K, et al. (1989). Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. U. S. A. 86: 2766-2770.
27. Osbak KK, Colclough K, Saint-Martin C, Beer NL, et al. (2009). Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum. Mutat. 30: 1512-1526.
28. Printz RL, Magnuson MA and Granner DK (1993). Mammalian glucokinase. Annu. Rev. Nutr. 13: 463-496.
29. Riskin-Mashiah S, Younes G, Damti A and Auslender R (2009). First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 32: 1639-1643.
30. Rivero K, Portal VL, Vieira M and Behle I (2008). Prevalence of the impaired glucose metabolism and its association with risk factors for coronary artery disease in women with gestational diabetes. Diabetes Res. Clin. Pract. 79: 433-437.
31. Rose CS, Ek J, Urhammer SA, Glumer C, et al. (2005). A-30G>A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites. Diabetes 54: 3026-3031.
32. Rosenberg TJ, Garbers S, Lipkind H and Chiasson MA (2005). Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am. J. Public. Health 95: 1545-1551.
33. Rubio-Cabezas O, Klupa T and Malecki MT (2011). Permanent neonatal diabetes mellitus-the importance of diabetes differential diagnosis in neonates and infants. Eur. J. Clin. Invest. 41: 323-333.
34. Ruzzo A, Andreoni F and Magnani M (1998). Structure of the human hexokinase type I gene and nucleotide sequence of the 5' flanking region. Biochem. J. 331 (Pt 2): 607-613.
35. Santos IC, Daga DR, Frigeri HR, Rea RR, et al. (2010a). The functional polymorphisms-429T>C and-374T>A of the RAGE gene promoter are not associated with gestational diabetes in Euro-Brazilians. Genet. Mol. Res. 9: 1130-1135.
36. Santos IC, Frigeri HR, Rea RR, Almeida AC, et al. (2010b). The glucokinase gene promoter polymorphism-30G>A (rs1799884) is associated with fasting glucose in healthy pregnant women but not with gestational diabetes. Clin. Chim. Acta 411: 892-893.
37. Schmidt MI, Matos MC, Reichelt AJ, Forti AC, et al. (2000). Prevalence of gestational diabetes mellitus-do the new WHO criteria make a difference? Brazilian Gestational Diabetes Study Group. Diabet. Med. 17: 376-380.
38. Souza RL, Mikami LR, Maegawa RO and Chautard-Freire-Maia EA (2005). Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample. Mol. Genet. Metab. 84: 349-353.
39. Stoffel M, Froguel P, Takeda J, Zouali H, et al. (1992). Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 89: 7698-7702.
40. Tinto N, Zagari A, Capuano M, De Simone A, et al. (2008). Glucokinase gene mutations: structural and genotype-phenotype analyses in MODY children from South Italy. PLoS One 3: e1870.
41. Weedon MN, Frayling TM, Shields B, Knight B, et al. (2005). Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene. Diabetes 54: 576-581.